View in EDS

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.

Saved in:
Bibliographic Details
Title: The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.
Authors: Chaccour C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Clínica Universidad de Navarra, Pamplona, Spain.; Ifakara Health Institute, Ifakara, Tanzania., Casellas A; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain., Blanco-Di Matteo A; Clínica Universidad de Navarra, Pamplona, Spain., Pineda I; Clínica Universidad de Navarra, Pamplona, Spain., Fernandez-Montero A; Clínica Universidad de Navarra, Pamplona, Spain., Ruiz-Castillo P; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Richardson MA; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Rodríguez-Mateos M; Clínica Universidad de Navarra, Pamplona, Spain., Jordán-Iborra C; Clínica Universidad de Navarra, Pamplona, Spain., Brew J; Databrew, Gainesville, FL, United States., Carmona-Torre F; Clínica Universidad de Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Giráldez M; Clínica Universidad de Navarra, Pamplona, Spain., Laso E; Clínica Universidad de Navarra, Pamplona, Spain., Gabaldón-Figueira JC; Clínica Universidad de Navarra, Pamplona, Spain., Dobaño C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Moncunill G; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Harvard T.H. Chan School of Public Health, Boston, MA, United States., Yuste JR; Clínica Universidad de Navarra, Pamplona, Spain., Del Pozo JL; Clínica Universidad de Navarra, Pamplona, Spain., Rabinovich NR; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Harvard T.H. Chan School of Public Health, Boston, MA, United States., Schöning V; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland., Hammann F; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland., Reina G; Clínica Universidad de Navarra, Pamplona, Spain.; Harvard T.H. Chan School of Public Health, Boston, MA, United States., Sadaba B; Clínica Universidad de Navarra, Pamplona, Spain., Fernández-Alonso M; Clínica Universidad de Navarra, Pamplona, Spain.
Source: EClinicalMedicine [EClinicalMedicine] 2021 Feb; Vol. 32, pp. 100720. Date of Electronic Publication: 2021 Jan 19.
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2020.100720